tirzepatide generic canada approves semaglutide from Dr. Reddy's, a G7 first enabled by Novo Nordisk's lapsed CAD$250 patent Tirzepatide | The Peptide Labs

Inflammopharmacol 25 , 439449 (2017)

10.1038/s41392-022-01024-9 183 TaylorD

Boye and colleagues remind us that people are more likely to adhere to therapies that they value, likely resulting in improved clinical outcomes, and that people place value on various attributes of treatment, including efficacy, safety and ease of use

How it works: Semaglutide works by mimicking a hormone called glucagon-like peptide-1 (GLP-1) that targets areas of the brain that regulate appetite, craving and food intake

Of those entering the study, 14 had normal renal function, 11 had mild RI, 11 had moderate RI, ten had severe RI, and ten had ESRD requiring hemodialysis